How Do GLP-1 Medications Work? The Science Explained

How GLP-1 Medications Produce Weight Loss

GLP-1 medications are among the most effective weight loss treatments ever developed. But how do they actually work? Here is the science, explained in plain language.

What Is GLP-1?

GLP-1 stands for **glucagon-like peptide-1**. It is a hormone naturally produced by cells in your small intestine after you eat. In your body, natural GLP-1:

1. **Signals fullness to the brain** -- GLP-1 receptors in the hypothalamus (the brain's appetite control center) receive the signal and reduce hunger

2. **Slows gastric emptying** -- food moves more slowly from the stomach to the small intestine, keeping you feeling satisfied longer

3. **Stimulates insulin release** -- but only when blood sugar is elevated (this is called glucose-dependent insulin secretion)

4. **Suppresses glucagon** -- reduces the hormone that raises blood sugar

The problem is that natural GLP-1 breaks down within minutes. GLP-1 medications are engineered to last much longer.

GLP-1 Receptor Agonists (Semaglutide, Liraglutide)

Semaglutide (the active ingredient in Wegovy and Ozempic) and liraglutide (Saxenda) are GLP-1 receptor agonists. They mimic natural GLP-1 but are modified to resist breakdown:

Both work primarily through the GLP-1 receptor, reducing appetite and food intake.

Dual GIP/GLP-1 Receptor Agonists (Tirzepatide)

Tirzepatide (the active ingredient in Zepbound and Mounjaro) represents the next evolution. It is a 39-amino acid synthetic peptide that activates **two** receptors:

1. **GLP-1 receptor** -- the same target as semaglutide

2. **GIP receptor** -- glucose-dependent insulinotropic polypeptide receptor

Research published in JCI Insight describes tirzepatide as an "imbalanced and biased dual GIP and GLP-1 receptor agonist," meaning it has particularly strong affinity for the GIP receptor and produces different signaling patterns at the GLP-1 receptor compared to native GLP-1.

**What GIP receptor activation adds:**

*Source: Willard FS, et al. JCI Insight 2020;5(17):e140532.*

Why the Weight Loss Is Substantial

Previous weight loss medications primarily targeted a single pathway. GLP-1 medications work through multiple simultaneous mechanisms:

This multi-mechanism approach explains why clinical trial results are so much more robust than older medications. Semaglutide produces approximately 15% average weight loss, while tirzepatide achieves up to 22.5% at the highest dose.

Beyond Weight Loss

Research increasingly suggests GLP-1 medications have effects beyond weight reduction:

Scientists are still working to fully understand all the mechanisms at play. Clinical trials are ongoing for potential benefits in heart failure, kidney disease, liver disease, and other conditions.

*This article explains the scientific mechanisms of GLP-1 medications based on published peer-reviewed research. It is not medical advice. Consult a healthcare provider about treatment options.*